Search Within

Heiko Schoder

  1. "Breast Medicine Service"
Formats
  1. Meeting Abstract (15)
  2. Journal Article (11)
Groups
  1. Breast Medicine Service (26)
  2. Department of Medicine (26)
  3. Molecular Imaging and Therapy Service (26)
  4. Radiology, Department of (26)
  5. Solid Tumor Oncology Division (26)
  6. Survivorship Research (21)

More Groups

People
  1. Pamela Drullinsky (17)
  2. Andrew Zelenetz (16)
  3. Anita Kumar (16)
  4. David Straus (16)
  5. Matthew Matasar (16)
  6. Alison Moskowitz (14)

More People

Years
  1. 2024 (2)
  2. 2022 (2)
  3. 2021 (3)
  4. 2020 (2)
  5. 2019 (3)
  6. 2018 (3)

More Years

Publications
  1. Blood (8)
  2. Journal of Clinical Oncology (5)
  3. Hematological Oncology (3)
  4. Clinical Cancer Research (2)
  5. Breast Cancer Research and Treatment (1)
  6. Cancer (1)

More Publications

Publishers
  1. American Society of Hematology (8)
  2. American Society of Clinical Oncology (5)
  3. Wiley Blackwell (4)
  4. American Association for Cancer Research (3)
  5. Oxford University Press (2)
  6. Springer (2)

More Publishers

Results (26)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Yahalom, J.; Schòˆder, H.; Barr, P. M.; Caron, P.; Chiu, A.; Constine, L. S.; Drullinsky, P.; Friedberg, J. W.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging to evaluate treatment response after WBRT sorafenib
    Meeting Abstract

    Morikawa, A.; Jhaveri, K. L.; Patil, S.; Chen, M.; Mcdonnell, E.; Neville, D. A.; Mak, F. M.; Gansukh, B.; Humm, J. L.; Holodny, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • A prospective evaluation of the utility of 2-deoxy-2-[ 18F] fluoro- D -glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer
    Journal Article

    Smyth, E.; Schoder, H.; Strong, V. E.; Capanu, M.; Kelsen, D. P.; Coit, D. G.; Shah, M. A.
    Cancer (2012)

    Fulltext@MSK | Save
  • Perioperative chemotherapy plus bevacizumab with early salvage therapy based on PET response in patients with locally advanced resectable gastric/GEJ cancer
    Meeting Abstract

    Smyth, E. C.; Schoder, H.; Coit, D. G.; Strong, V. E.; Brennan, M. F.; Janjigian, Y. Y.; Capanu, M.; Tang, L. H.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy
    Journal Article

    Estilo, C. L.; Van Poznak, C. H.; Williams, T.; Bohle, G. C.; Lwin, P. T.; Zhou, Q.; Riedel, E. R.; Carlson, D. L.; Schoder, H.; Farooki, A.; more...
    The Oncologist (2008)

    Fulltext@MSK | Save